文献速递精神分裂症与精神病性障碍

氯胺酮作为精神分裂症全病程丘脑连接异常药理模型的验证

Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.
PubMed 文献 · Mol Psychiatry · 2022-04-14

该双盲安慰剂对照研究在健康志愿者中建立氯胺酮诱导的NMDAR功能低下丘脑连接模型,发现氯胺酮产生与感觉和运动区的丘脑-皮质超连接,且拉莫三嗪预处理未减弱此效应;该模式与慢性及早期精神分裂症患者的丘脑连接异常相似,且相似系数与幻听严重度相关。

要点

  • 氯胺酮诱导健康志愿者丘脑与感觉、运动区超连接,拉莫三嗪预处理未减弱。
  • 氯胺酮丘脑连接模式与慢性及早期精神分裂症患者相似,临床高危者呈中间趋势。
  • 氯胺酮相似系数越高,精神分裂症患者幻听严重度越高。

核心结论

  • 氯胺酮模拟的NMDAR功能低下可重现精神分裂症全病程(包括精神病发作前临床高危期)的丘脑超连接,并可能参与幻听严重度。

研究设计与样本

  • 双盲、安慰剂对照研究,在健康志愿者接受氯胺酮输注期间进行静息态功能磁共振成像(rsfMRI),并测试拉莫三嗪预处理的影响。
  • 将氯胺酮丘脑连接效应全脑模板与慢性精神分裂症(SZ)、早期精神分裂症(ESZ)、临床高危(CHR-P)及健康对照(HC)的个体rsfMRI丘脑连接图相关,生成氯胺酮相似系数。

主要发现

  • 氯胺酮产生与感觉和运动区的丘脑-皮质超连接,拉莫三嗪预处理未减弱该效应。
  • SZ和ESZ的氯胺酮相似系数高于HC,CHR-P呈中间趋势。
  • 在SZ中,较高的氯胺酮相似系数与更严重的幻听相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizophrenia. Resting-state functional magnetic resonance imaging (rsfMRI) studies demonstrate a thalamic dysconnectivity pattern in schizophrenia involving excessive connectivity with sensory regions and deficient connectivity with frontal, cerebellar, and thalamic regions. The NMDAR antagonist ketamine, when administered at sub-anesthetic doses to healthy volunteers, induces transient schizophrenia-like symptoms and alters rsfMRI thalamic connectivity. However, the extent to which ketamine-induced thalamic dysconnectivity resembles schizophrenia thalamic dysconnectivity has not been directly tested. The current double-blind, placebo-controlled study derived an NMDAR hypofunction model of thalamic dysconnectivity from healthy volunteers undergoing ketamine infusions during rsfMRI. To assess whether ketamine-induced thalamic dysconnectivity was mediated by excess glutamate release, we tested whether pre-treatment with lamotrigine, a glutamate release inhibitor, attenuated ketamine's effects. Ketamine produced robust thalamo-cortical hyper-connectivity with sensory and motor regions that was not reduced by lamotrigine pre-treatment. To test whether the ketamine thalamic dysconnectivity pattern resembled the schizophrenia pattern, a whole-brain template representing ketamine's thalamic dysconnectivity effect was correlated with individual participant rsfMRI thalamic dysconnectivity maps, generating "ketamine similarity coefficients" for people with chronic (SZ) and early illness (ESZ) schizophrenia, individuals at clinical high-risk for psychosis (CHR-P), and healthy controls (HC). Similarity coefficients were higher in SZ and ESZ than in HC, with CHR-P showing an intermediate trend. Higher ketamine similarity coefficients correlated with greater hallucination severity in SZ. Thus, NMDAR hypofunction, modeled with ketamine, reproduces the thalamic hyper-connectivity observed in schizophrenia across its illness course, including the CHR-P period preceding psychosis onset, and may contribute to hallucination severity.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Abram SV, Roach BJ, Fryer SL, et al. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry. 2022. PMID: 35422467. doi:10.1038/s41380-022-01502-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。